Hikal Ltd Share Price
(HIKAL)
₹401.8▲4.81%
as on 04:01PM, 18 Mar 2025
Hikal Performance
Day's Low
Day's High
₹384.6Day's Price Range₹40552 Week's Low
52 Week's High
₹260.352-Week Price Range₹464.75
| Returns % | |
| 1 Month Return | + 11.16 % |
| 3 Month Return | -3.46 % |
| 1 Year Return | + 41.98 % |
| Market Stats | |
| Previous Close | ₹383.35 |
| Open | ₹387.20 |
| Volume | 3.72L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹4,726.73Cr |
Hikal Fundamentals
P/E Ratio
63.47
PEG Ratio
275.95
Market Cap
₹4,726.73 Cr
P/B Ratio
2.75
EPS
5.64
Dividend Yield
0.45
Sector
Pharmaceuticals
ROE
5.99
Mutual Fund Holdings of Hikal
Hikal Analyst Rating
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts offering long term price targets for Hikal. An average target of ₹435
Source: S&P Global Market Intelligence
Hikal Share analysis
Hikal price forecast by 2 analysts
Upside of13.47%
High
₹450
Target
₹435.00
Low
₹420
Hikal target price ₹435, a slight upside of 13.47% compared to current price of ₹401.8. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Hikal revenue growth forecast
Expected growth rate Q1, FY2027:36.71%
Forecast
Actual
Including amortisation and stock based compensations
Hikal EPS growth forecast
EPS estimate Q1, FY2027:151.77%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Hikal Ltd
Hikal Stock Shows Bullish Momentum - 12 Mar, 2025
Hikal stock has broken out from a bullish inverted head and shoulder pattern, forming higher tops and bottoms. Indicators and oscillators are bullish on both daily and weekly charts.Bullish Sentiment for Hikal Stock in Pharma Sector - 05 Mar, 2025
Hikal Ltd shows strong bullish sentiment in the pharma sector, with recommendations to buy above ₹360 and targets set between ₹385-395, indicating positive market momentum.
Insights on Hikal Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 20.79% to 21.61% in Dec 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, HIKAL stock has moved up by 11.2%
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 61.7% return, outperforming this stock by 19.7%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 121.9% return, outperforming this stock by 127.7%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.85% of holdings in Dec 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 6.78% to 6.06% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 453.3 Cr → 451.3 Cr (in ₹), with an average decrease of 0.4% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 18.3 Cr → 17.2 Cr (in ₹), with an average decrease of 6.0% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 3.22% to 2.92% in Dec 2024 quarter
Hikal Financials
Hikal Index Inclusions
Hikal Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.85% | 0.00 | |
| Foreign Institutions | 6.06% | ||
| Mutual Funds | 2.92% | ||
| Retail Investors | 21.61% | 3.93 | |
| Others | 0.56% | 55.28 |
Hikal Key Indicators
Hikal Valuation
Hikal in the last 5 years
Lowest (8.33x)
March 24, 2020
Industry (50.70x)
March 17, 2025
Today (63.47x)
March 17, 2025
Highest (81.58x)
January 3, 2023
Hikal Earnings and Dividends
Hikal Ltd Earnings Results
Hikal Ltd’s net profit jumped 6.83% since last year same period to ₹17.20Cr in the Q3 2024-2025. On a quarterly growth basis, Hikal Ltd has generated -6.01% fall in its net profits since last 3-months.
Read More about Earnings ResultsHikal Ltd Dividends February,2025
In the quarter ending December 2024, Hikal Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.45%.
Read More about Dividends
Hikal Technicals Summary
Bearish
Neutral
Bullish
Hikal Ltd is currently in a Bullish trading position according to technical analysis indicators.
Hikal Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹4,726.73 Cr | 81.89% | 0.72 | ₹69 Cr | ₹1,784 Cr | |
| BUY | ₹28,896.94 Cr | 157.81% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹13,639.27 Cr | 49.71% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹3,805.02 Cr | 3.66% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹12,694.97 Cr | 35.54% | 0.68 | ₹218 Cr | ₹1,296 Cr |
About Hikal
Revenue: ₹438.90Cr as on December 2024 (Q4 24)
Net Profit: ₹17.20Cr as on December 2024 (Q4 24)
Listing date: 14 Feb, 2001
Chairperson Name: Jai Hiremath
| Organisation | Hikal |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Hikal Ltd
What is Hikal Ltd price today?
Hikal Ltd share price today stands at ₹401.8, Open: ₹387.2, Previous Close: ₹383.35, High: ₹405, Low: ₹384.6, 52 Week High: ₹464.75, 52 Week Low: ₹260.3.
How to Buy Hikal Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Hikal Ltd shares
What are today's traded volumes of Hikal Ltd?
Today's traded volume of Hikal Ltd(HIKAL) is 3.72L.
What is today's market capitalisation of Hikal Ltd?
Today's market capitalisation of Hikal Ltd(HIKAL) is ₹4726.73Cr.
What is the 52 Week High and Low Range of Hikal Ltd?
How much percentage Hikal Ltd is down from its 52 Week High?
Hikal Ltd (HIKAL) share price is ₹401.8. It is down -13.54% from its 52 Week High price of ₹464.75
How much percentage Hikal Ltd is up from its 52 Week low?
Hikal Ltd (HIKAL) share price is ₹401.8. It is up 54.36% from its 52 Week Low price of ₹260.3